What they were paid
Compass Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $45,000 | $0 | $108,400 | $0 | $153,400 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Compass Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001140361-26-017649, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Compass Therapeutics pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Compass Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carl L. Gordon | Independent Director | $173,400 |
| Ellen V. Chiniara | Independent Director | $168,400 |
| James P. Boylan | Independent Director | $158,400 |
| Philip J. Ferneau | Independent Director | $163,400 |
| Richard S. Lindahl | Independent Director | $163,400 |
| Thomas J. Schuetz | Director | $0 |
The full Compass Therapeutics compensation record
free company briefThis page is one director within Compass Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat